Connecticut · Medicaid and GLP-1s

Does Connecticut Medicaid cover Wegovy or Zepbound?

Last updated

No: Connecticut Medicaid does not cover GLP-1s for weight loss alone.

Without Medicaid: the lowest cash prices in Connecticut

  • Lowest compounded semaglutide in Connecticut on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $29 less over a year than Sunlight, membership included · first order: membership free for the first 21 days, never charged if you cancel before

  • Next lowest per 30 days, supply stated: compounded semaglutide in Connecticut

    Sunlight

    $78/mo · ≈ $84 per 30 days

  • Lowest compounded tirzepatide in Connecticut on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $389 less over a year than FlatRx, membership included · first order: membership free for the first 21 days, never charged if you cancel before

  • Next lowest per 30 days, supply stated: compounded tirzepatide in Connecticut

    SexyMD

    $129/mo · ≈ $138 per 30 days

  • F

    Lowest month to month, no yearly fee: compounded tirzepatide in Connecticut

    FlatRx

    $118/mo

  • Lowest compounded liraglutide in Connecticut on a monthly plan, not FDA-approved

    NuBloom

    $408.99/4 weeks

  • Lowest month to month, no yearly fee: compounded liraglutide in Connecticut

    Alloy

    from $115/mo

No, not for weight loss alone: Connecticut Medicaid is not one of the 13 programs KFF counted covering GLP-1s for obesity treatment as of January 2026 (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026). KFF notes Connecticut covers one or more other weight-loss drugs, but no GLP-1. Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively". Paying cash in Connecticut, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year) and compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year). Compounded medicines are not FDA-approved.

Questions

Connecticut Medicaid and GLP-1s: common questions

Does Connecticut Medicaid cover Wegovy?

For weight loss alone, no: Connecticut Medicaid does not cover GLP-1s for weight loss alone. Every Medicaid program must cover Wegovy for the treatment of cardiovascular disease, KFF notes, with the state's own criteria. Wegovy not covered: the cash price at your dose

Does Connecticut Medicaid cover Zepbound?

For weight loss alone, no: Connecticut Medicaid does not cover GLP-1s for weight loss alone. Every Medicaid program must cover Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, KFF notes, with the state's own criteria. Zepbound not covered: the cash price at your dose

Does Connecticut Medicaid cover Ozempic or Mounjaro?

For type 2 diabetes, yes: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively." Ozempic and Mounjaro are approved for type 2 diabetes. For weight loss alone, no: Connecticut Medicaid does not cover GLP-1s for weight loss alone.

How much do Wegovy and Zepbound alternatives cost in Connecticut without Medicaid?

Paying cash in Connecticut, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year) and compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year). Compounded medicines are not FDA-approved. Semaglutide: advertised as $59/mo + $199/yr membership at Collective, checked Nov 15, 2026 on collective.org. Tirzepatide: advertised as $69/mo + $199/yr membership at Collective, checked Nov 15, 2026 on collective.org. Liraglutide: advertised as $408.99/4 weeks at NuBloom, checked Nov 14, 2026 on mynubloom.com. Every compounded price in Connecticut

Which states' Medicaid covers GLP-1s for weight loss?

10 programs, by KFF's January 2026 map and the states' own notices since: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin. Every state's Medicaid and GLP-1s

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a Medicaid plan covers is decided by the plan and the state, and changes; ask your plan before you rely on it. This page reports the state's and KFF's published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.